Clinical Trial Update: A Study to Evaluate INCA035784 in Participants With Myeloproliferative Neoplasms [Phase 1]

View source ↗

Summary

This clinical trial update describes a Phase 1 study evaluating INCA035784 in participants with myeloproliferative neoplasms, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myeloproliferative Neoplasms

Drugs mentioned

• INCA035784

Snippet

Sponsor: Incyte Corporation | Conditions: Myeloproliferative Neoplasms | Phase 1 | Status: RECRUITING